IBDEI2X1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46503,0)
 ;;=H34.8110^^176^2313^22
 ;;^UTILITY(U,$J,358.3,46503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46503,1,3,0)
 ;;=3^CRVO w/ CME,RIGHT eye               
 ;;^UTILITY(U,$J,358.3,46503,1,4,0)
 ;;=4^H34.8110
 ;;^UTILITY(U,$J,358.3,46503,2)
 ;;=^5138476
 ;;^UTILITY(U,$J,358.3,46504,0)
 ;;=H34.8120^^176^2313^23
 ;;^UTILITY(U,$J,358.3,46504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46504,1,3,0)
 ;;=3^CRVO w/ CME,LEFT eye                
 ;;^UTILITY(U,$J,358.3,46504,1,4,0)
 ;;=4^H34.8120
 ;;^UTILITY(U,$J,358.3,46504,2)
 ;;=^5138479
 ;;^UTILITY(U,$J,358.3,46505,0)
 ;;=H21.1X1^^176^2313^24
 ;;^UTILITY(U,$J,358.3,46505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46505,1,3,0)
 ;;=3^NVI/NVA/Rubeosis,RIGHT eye          
 ;;^UTILITY(U,$J,358.3,46505,1,4,0)
 ;;=4^H21.1X1
 ;;^UTILITY(U,$J,358.3,46505,2)
 ;;=^5005175
 ;;^UTILITY(U,$J,358.3,46506,0)
 ;;=H21.1X2^^176^2313^25
 ;;^UTILITY(U,$J,358.3,46506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46506,1,3,0)
 ;;=3^NVI/NVA/Rubeosis,Left eye           
 ;;^UTILITY(U,$J,358.3,46506,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,46506,2)
 ;;=^5005176
 ;;^UTILITY(U,$J,358.3,46507,0)
 ;;=H35.711^^176^2313^26
 ;;^UTILITY(U,$J,358.3,46507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46507,1,3,0)
 ;;=3^Central Serous Retinopathy,RIGHT eye
 ;;^UTILITY(U,$J,358.3,46507,1,4,0)
 ;;=4^H35.711
 ;;^UTILITY(U,$J,358.3,46507,2)
 ;;=^5005703
 ;;^UTILITY(U,$J,358.3,46508,0)
 ;;=H35.712^^176^2313^27
 ;;^UTILITY(U,$J,358.3,46508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46508,1,3,0)
 ;;=3^Central Serous Retinopathy,LEFT eye 
 ;;^UTILITY(U,$J,358.3,46508,1,4,0)
 ;;=4^H35.712
 ;;^UTILITY(U,$J,358.3,46508,2)
 ;;=^5005704
 ;;^UTILITY(U,$J,358.3,46509,0)
 ;;=E11.9^^176^2314^2
 ;;^UTILITY(U,$J,358.3,46509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46509,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,46509,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,46509,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,46510,0)
 ;;=E11.39^^176^2314^1
 ;;^UTILITY(U,$J,358.3,46510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46510,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,46510,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,46510,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,46511,0)
 ;;=E10.9^^176^2314^21
 ;;^UTILITY(U,$J,358.3,46511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46511,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,46511,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,46511,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,46512,0)
 ;;=E10.39^^176^2314^20
 ;;^UTILITY(U,$J,358.3,46512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46512,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,46512,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,46512,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,46513,0)
 ;;=E10.3291^^176^2314^22
 ;;^UTILITY(U,$J,358.3,46513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46513,1,3,0)
 ;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,46513,1,4,0)
 ;;=4^E10.3291
 ;;^UTILITY(U,$J,358.3,46513,2)
 ;;=^5138283
 ;;^UTILITY(U,$J,358.3,46514,0)
 ;;=E10.3292^^176^2314^27
 ;;^UTILITY(U,$J,358.3,46514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46514,1,3,0)
 ;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,46514,1,4,0)
 ;;=4^E10.3292
